Healthy Volunteers With Hyperlipidemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Healthy Volunteers With Hyperlipidemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06894251

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

The goal of this clinical trial is to observe a decrease in plasma LDL cholesterol concentration of 10% (or 0.20g/L) in subjects with untreated moderate hyperch…

France35 participantsStarted 2025-03-10

Treatment: LIMICOL® NG

All recent trials (46 shown)

Active — Not RecruitingPhase 1

NCT06452771

A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults

This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on healthy participants with an elevated level of blo…

New Zealand59 participantsStarted 2024-06-27

Treatment: ALN-ANG3, Placebo (PB)

Not Yet RecruitingPhase 1

NCT07322016

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

The primary objective of this study is to evaluate pharmacokinetics of HRS-1301 tablets in subjects with impaired kidney function in comparison with healthy sub…

China36 participantsStarted 2026-01

Treatment: HRS-1301 Tablet

Healthy Volunteers With Hyperlipidemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

All recent trials (46 shown)

A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

All recent trials (46 shown)

A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndr…

A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants

Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects

A Study to Assess the Safety and Pharmacokinetics of AD-104-A

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

Effect of a Dietary Supplement on Lipid Pattern, Indexes of NAFLD and Systemic Inflammation in Healthy Subjects With Sub…

Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver…

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C…

A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401

A First in Human Study of STT-5058, an Antibody That Binds ApoC3

A Phase 1, First Time in Humans Study of NST-1024

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317…

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hyperchol…